Comparative NanoUPLC-MSE analysis between magainin I-susceptible and -resistant Escherichia coli strains. 2017

Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
Centro de Análises Proteômicas e Bioquímicas, Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília-DF, 70.790-160, Brazil.

In recent years the antimicrobial peptides (AMPs) have been prospected and designed as new alternatives to conventional antibiotics. Indeed, AMPs have presented great potential toward pathogenic bacterial strains by means of complex mechanisms of action. However, reports have increasingly emerged regarding the mechanisms by which bacteria resist AMP administration. In this context, we performed a comparative proteomic study by using the total bacterial lysate of magainin I-susceptible and -resistant E. coli strains. After nanoUPLC-MSE analyses we identified 742 proteins distributed among the experimental groups, and 25 proteins were differentially expressed in the resistant strains. Among them 10 proteins involved in bacterial resistance, homeostasis, nutrition and protein transport were upregulated, while 15 proteins related to bacterial surface modifications, genetic information and β-lactams binding-protein were downregulated. Moreover, 60 exclusive proteins were identified in the resistant strains, among which biofilm and cell wall formation and multidrug efflux pump proteins could be observed. Thus, differentially from previous studies that could only associate single proteins to AMP bacterial resistance, data here reported show that several metabolic pathways may be related to E. coli resistance to AMPs, revealing the crucial role of multiple "omics" studies in order to elucidate the global molecular mechanisms involved in this resistance.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D054806 Magainins A class of antimicrobial peptides discovered in the skin of XENOPUS LAEVIS. They kill bacteria by permeabilizing cell membranes without exhibiting significant toxicity against mammalian cells. Magainin
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance
D029968 Escherichia coli Proteins Proteins obtained from ESCHERICHIA COLI. E coli Proteins
D036103 Nanotechnology The development and use of techniques to study physical phenomena and construct structures in the nanoscale size range or smaller. Nanotechnologies

Related Publications

Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
December 2021, Microbiology resource announcements,
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
August 1960, Antibiotics & chemotherapy (Northfield, Ill.),
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
June 1976, Antimicrobial agents and chemotherapy,
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
October 2014, The Journal of antibiotics,
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
April 2008, Infection control and hospital epidemiology,
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
December 2015, Journal of water and health,
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
May 2022, Parasites & vectors,
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
March 1994, Antimicrobial agents and chemotherapy,
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
November 2018, Pest management science,
Marlon H Cardoso, and Keyla C de Almeida, and Elizabete de S Cândido, and André M Murad, and Simoni C Dias, and Octávio L Franco
November 2015, BMC genomics,
Copied contents to your clipboard!